S-1/A: Beachbody Files Amendment No. 2 to Form S-1 for Resale of Class A Common Stock
S-1/A Filing
Beachbody files an amendment to its registration statement for the resale of up to 543,590 shares of Class A common stock issuable upon exercise of outstanding warrants.
Summary
- Beachbody has filed an amendment to its registration statement for the resale of Class A common stock.
- The filing pertains to the resale of up to 543,590 shares of Class A common stock.
- These shares are issuable upon the exercise of outstanding warrants.
- The common warrants were issued in a private placement completed on December 13, 2023.
- The exercise price of the warrants is $11.24 per share.
- The warrants are exercisable beginning six months after the issuance date and expire five and a half years from the issuance date.
- If all common warrants are exercised for cash, Beachbody would receive approximately $6.1 million in proceeds.
- The company will use the net proceeds from any cash exercise of the Common Warrants for working capital and general corporate purposes.
- On June 10, 2024, the last reported sales price of Beachbody's Class A Common Stock on the NYSE was $8.75 per share.
- The document also mentions recent developments including an equity offering, a reverse stock split, goodwill and intangible asset impairments, and amendments to a financing agreement.
Sentiment
Score: 4
Explanation: The document contains a mix of positive and negative elements. While cost-cutting measures and potential cash influx from warrant exercises are positive, declining revenues, impairments, and a stock price below the warrant exercise price contribute to a negative sentiment. Overall, the sentiment is cautiously pessimistic.
Positives
- Potential influx of $6.1 million if all warrants are exercised for cash.
- Proceeds from warrant exercises will be used for working capital and general corporate purposes.
- Sale of Van Nuys production facility generated $6.2 million in proceeds and a partial prepayment of $5.5 million on the Term Loan.
- Cost-reduction initiatives in January 2024 aim to streamline operations.
- Amendment to financing agreement provides more flexible financial covenants.
Negatives
- The last reported sales price of Beachbody's Class A Common Stock on June 10, 2024, was $8.75 per share, below the warrant exercise price of $11.24.
- Goodwill and intangible asset impairments of $40.0 million and $3.1 million, respectively, in 2023.
- Cost-reduction initiatives in January 2024 resulted in $1.6 million in costs.
- The company is dependent on a few key products.
Risks
- The market price of Class A Common Stock may experience volatility and drop below the price investors pay.
- Investors may experience future dilution from equity offerings.
- The number of shares of Class A Common Stock available for future issuance or resale could adversely affect the market price.
- The company relies on consumer discretionary spending, which may be adversely affected by economic downturns and other macroeconomic conditions or trends.
- The company has limited control over its suppliers, manufacturers, and logistics providers, which may subject it to significant risks.
- The company's financing agreement restricts its current and future operations and its ability to engage in certain business and financial transactions.
- The company's ability to generate the significant amount of cash needed to pay interest and principal on its indebtedness and its ability to refinance all or a portion of its indebtedness or obtain additional financing depends on many factors beyond its control.
Future Outlook
The company expects to generate additional liquidity through continued cost control initiatives and believes that existing cash and cash equivalents will provide sufficient liquidity to meet anticipated cash needs, including debt service requirements, for the next twelve months and beyond.
Industry Context
The document highlights Beachbody's position in the competitive health and wellness market, noting competition from at-home fitness solutions, digital fitness apps, and weight management programs. The emergence of GLP-1 weight loss drugs is also mentioned as a factor influencing the market.
Comparison to Industry Standards
- The document does not provide a direct comparison to industry standards.
- However, it mentions that Beachbody's annual connected fitness subscription of $179 equates to an average monthly price of $15.00 during 2023, which is less expensive than most monthly gym memberships and boutique studio fitness classes.
- This suggests a competitive pricing strategy compared to traditional fitness options.
Legal Proceedings
- The document mentions ongoing legal proceedings, including a class action complaint regarding the classification of Partners and a patent infringement claim by DISH Entities.
Stakeholder Impact
- Shareholders may experience dilution from future equity offerings.
- Employees may be affected by cost-reduction initiatives and restructuring.
- Customers may be impacted by changes in product offerings and pricing.
Next Steps
- The selling shareholders may sell, transfer or otherwise dispose of any or all of their Class A Common Stock.
- The company intends to use the net proceeds from any cash exercise of the Common Warrants for working capital and general corporate purposes.
Key Dates
| Date | Description |
|---|---|
| 2017-12-31 | Date before which no dates are listed. |
| 2020-12-31 | Date before which no dates are listed. |
| 2020-09-24 | Date of incorporation of Forest Road Acquisition Corp. |
| 2021-01-01 | Start of period for financial data. |
| 2021-06-24 | Date of special meeting of stockholders. |
| 2021-06-25 | Date of name change to The Beachbody Company, Inc. |
| 2021-12-22 | Date of ForestRoad EarnOutSharesMember. |
| 2022-01-01 | Start of period for financial data. |
| 2022-04-07 | Date of LetterIssuedByGeneralCorporationLawOfStateOfDelawareForSharesNotApprovedMember. |
| 2022-08-08 | Date of SeniorSecuredTermLoanMember. |
| 2023-01-01 | Start of period for financial data. |
| 2023-03-31 | End of period for financial data. |
| 2023-06-15 | Date of TheForfeitureAgreementMember. |
| 2023-06-15 | Date of InducementPlanMember. |
| 2023-06-14 | Date of InducementPlanMember. |
| 2023-07-01 | Start of period for financial data. |
| 2023-07-24 | Date of SeniorSecuredTermLoanMember. |
| 2023-09-14 | Date of AmendedUnderwaterOptionsMember. |
| 2023-09-29 | Date of FinancingAgreementWithIpfsMember. |
| 2023-09-30 | End of period for financial data. |
| 2023-10-01 | Date of SeniorSecuredTermLoanMember. |
| 2023-10-06 | Date of FinancingAgreementWithFirstInsuranceFundingMember. |
| 2023-11-20 | Date of Reverse Stock Split. |
| 2023-11-21 | Date of Reverse Stock Split. |
| 2023-11-24 | Date of PublicWarrantsMember. |
| 2023-12-10 | Date of SecuritiesPurchaseAgreementMember. |
| 2023-12-13 | Date of Common Warrants issuance. |
| 2023-12-31 | End of period for financial data. |
| 2024-01-01 | Start of period for financial data. |
| 2024-01-09 | Date of SeniorSecuredTermLoanMember. |
| 2024-01-12 | Date of investor exercising pre-funded warrants. |
| 2024-02-29 | Date of VanNuysProductionFacilityMember. |
| 2024-03-31 | End of period for financial data. |
| 2024-04-05 | Date of SeniorSecuredTermLoanMember. |
| 2024-06-10 | Date of last reported sales price of Class A Common Stock. |
| 2024-06-30 | Date of TermLoanWarrantsMember. |
Keywords
Class A Common Stock, Warrants, Resale, Equity Offering, Financing Agreement, Impairment, Beachbody, BODI, Debt, Financials
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.